Literature DB >> 19843029

Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.

J A Graham1, R A Wilkinson, T Hirohashi, C M Chase, R B Colvin, J C Madsen, J A Fishman, P S Russell.   

Abstract

Viral infections including those due to cytomegalovirus have been associated with accelerated cardiac allograft vasculopathy (CAV) in clinical trials and some animal models. Evidence demonstrating a direct causal relationship between such infections and de novo formation of coronary vascular lesions is lacking. Heterotopic murine cardiac transplants were performed in a parental to F1 combination in animals lacking both T- and B-lymphocytes (RAG(-/-)). Coronary vasculopathy developed almost exclusively in the presence of recipient infection with lymphocytic choriomeningitis virus but not in uninfected controls. This process was also dependent upon the presence of natural killer (NK) cells as depletion of NK cells abrogated the process. These data show that a viral infection in its native host, and not previously implicated in the production of CAV, can contribute to the development of advanced coronary vascular lesions in cardiac allotransplants in mice. These data also suggest that virus-induced CAV can develop via an NK-cell-dependent pathway in the absence of T- and B-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843029      PMCID: PMC2766593          DOI: 10.1111/j.1600-6143.2009.02801.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  33 in total

1.  Tolerance, mixed chimerism, and chronic transplant arteriopathy.

Authors:  P S Russell; C M Chase; M Sykes; H Ito; J Shaffer; R B Colvin
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

2.  Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection.

Authors:  R J Corry; H J Winn; P S Russell
Journal:  Transplantation       Date:  1973-10       Impact factor: 4.939

3.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

Review 4.  Cytomegalovirus infection and cardiac allograft vasculopathy.

Authors:  P K Koskinen; E A Kallio; J M Tikkanen; R K Sihvola; P J Häyry; K B Lemström
Journal:  Transpl Infect Dis       Date:  1999-06       Impact factor: 2.228

5.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

Authors:  M T Grattan; C E Moreno-Cabral; V A Starnes; P E Oyer; E B Stinson; N E Shumway
Journal:  JAMA       Date:  1989 Jun 23-30       Impact factor: 56.272

6.  Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.

Authors:  Elina I Zuniga; Li-Ying Liou; Lauren Mack; Marilyn Mendoza; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

Review 7.  Cardiac allograft vasculopathy after heart transplantation: risk factors and management.

Authors:  Hannah Valantine
Journal:  J Heart Lung Transplant       Date:  2004-05       Impact factor: 10.247

8.  Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.

Authors:  J F Bukowski; C A Biron; R M Welsh
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways.

Authors:  Linda Oberg; Sofia Johansson; Jakob Michaëlsson; Elena Tomasello; Eric Vivier; Klas Kärre; Petter Höglund
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

10.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  15 in total

1.  A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.

Authors:  T Hirohashi; C M Chase; P Della Pelle; D Sebastian; A Alessandrini; J C Madsen; P S Russell; R B Colvin
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

Review 2.  The Microbiome, Systemic Immune Function, and Allotransplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  Regadenoson-induced hyperemia for absolute myocardial blood flow quantitation by 13N-ammonia PET and detection of cardiac allograft vasculopathy.

Authors:  René R Sevag Packard; Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2017-01-30       Impact factor: 5.952

4.  Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.

Authors:  Xiaoming Shi; Mingjian Zhang; Fang Liu; Zhengxing Wang; Luding Zhang; Haifei Cheng; Shu Zhang; Teng Fei; Meng Guo; Jun Bian; Quanxing Wang; Guoshan Ding
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

5.  De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children.

Authors:  Laura E Hesemann; Vijay Subramanian; Thalachallour Mohanakumar; Vikas R Dharnidharka
Journal:  Pediatr Transplant       Date:  2015-06-09

6.  Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.

Authors:  Daniel Zecher; Qi Li; Amanda L Williams; John T Walters; Fady K Baddoura; Geetha Chalasani; David M Rothstein; Warren D Shlomchik; Anthony J Demetris; Fadi G Lakkis
Journal:  Transpl Immunol       Date:  2011-12-24       Impact factor: 1.708

7.  Depletion of T regulatory cells promotes natural killer cell-mediated cardiac allograft vasculopathy.

Authors:  Tsutomu Hirohashi; Catharine M Chase; Patricia DellaPelle; Divya Sebastian; Evan Farkesh; Robert B Colvin; Paul S Russell; Alessandro Alessandrini; Joren C Madsen
Journal:  Transplantation       Date:  2014-10-27       Impact factor: 4.939

8.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

Review 9.  Mechanisms of chronic cardiac allograft rejection.

Authors:  John P Costello; Thalachallour Mohanakumar; Dilip S Nath
Journal:  Tex Heart Inst J       Date:  2013

10.  Unlinked memory helper responses promote long-lasting humoral alloimmunity.

Authors:  Thomas M Conlon; Jennifer L Cole; Reza Motallebzadeh; Inês Harper; Chris J Callaghan; Eleanor M Bolton; J Andrew Bradley; Kourosh Saeb-Parsy; Gavin J Pettigrew
Journal:  J Immunol       Date:  2012-11-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.